Drug Name: | Co-trimoxazole |
---|
Drug Class: | Antibacterial combination |
---|
Mechanism of Action: | - Inhibits bacterial folate synthesis by blocking two consecutive steps in the biosynthesis of nucleic acids and proteins
- Sulfamethoxazole inhibits dihydropteroate synthase, while trimethoprim inhibits dihydrofolate reductase
|
---|
Use: | - Treatment of urinary tract infections
- Treatment of respiratory tract infections
- Treatment of gastrointestinal infections
- Treatment of skin and soft tissue infections
- Prophylaxis of Pneumocystis jirovecii pneumonia in immunocompromised patients
|
---|
Side Effects: | - Nausea
- Vomiting
- Diarrhea
- Rash
- Hypersensitivity reactions
- Photosensitivity
- Blood disorders (e.g. anemia, leukopenia, thrombocytopenia)
|
---|
Contraindications: | - Hypersensitivity to sulfonamides or trimethoprim
- Severe hepatic or renal impairment
- Pregnancy (especially in the first trimester)
|
---|
Specialty: | - Infectious disease
- Internal medicine
- Family medicine
|
---|